Lori D Lawley
CIK 1747716 · Chief Financial Officer · last filed 2024-12-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
16
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LUMOS PHARMA, INC. (LUMO) Delisted | Chief Financial Officer | 0 | $4.34 | $0 | $0 | 14 | 2024-12-13 |
| LUMOS PHARMA, INC. (NLNK) Delisted | Principal Accounting Officer | — | — | — | $0 | 2 | 2019-08-02 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-03 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | +3,750 | $0 | EDGAR |
| 2021-04-05 | LUMOS PHARMA, INC. (LUMO) Delisted | Tax (F) | −274 | -$3.4K | EDGAR |
| 2021-02-03 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | +869 | $0 | EDGAR |
| 2020-04-03 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2019-08-02 | LUMOS PHARMA, INC. (NLNK) Delisted | Mixed | — | $0 | EDGAR |
| 2019-03-05 | LUMOS PHARMA, INC. (NLNK) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.